Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Faster, Cleaner, Better.

Ngm Biopharmaceuticals Inc (NGM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2021	03-2021	12-2020	09-2020	06-2020
Assets
Current Assets
Cash & Cash Equivalents	99,403	148,113	147,017	253,976	249,317
Marketable Securities	291,147	264,543	148,139	33,973	62,778
Receivables	3,586	325	333	7,215	3,079
Other current assets	0	4,600	6,100	0	0
TOTAL	$403,129	$425,849	$308,426	$302,240	$322,622

Non-Current Assets
PPE Net	12,790	13,733	14,526	15,773	17,321
Other Non-Current Assets	7,092	5,959	6,091	8,069	7,341
TOTAL	$19,882	$19,692	$20,617	$23,842	$24,662

Total Assets	$423,011	$445,541	$329,043	$326,082	$347,284

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	5,141	7,535	9,663	1,613	1,934
Accrued Expenses	31,891	29,763	29,945	28,579	26,792
Other current liabilities	8,011	3,011	2,975	2,938	2,902
TOTAL	$45,043	$40,309	$42,583	$37,716	$33,702

Non-Current Liabilities
Deferred Revenues	N/A	N/A	N/A	4,586	2,074
Other Non-Current Liabilities	4,893	5,655	6,417	11,663	12,418
TOTAL	$4,893	$5,655	$6,417	$11,663	$12,418

Total Liabilities	$49,936	$45,964	$49,000	$49,379	$46,120

Shareholders' Equity
Shares Outstanding, K	77,338	77,018	76,692	69,019	68,828
Common Shares	77	77	71	69	69
Retained earnings	-362,867	-326,175	-298,631	-270,640	-240,875
Other shareholders' equity	5	-18	4	15	137
TOTAL	$373,075	$399,577	$280,043	$276,703	$301,164

Total Liabilities And Equity	$423,011	$445,541	$329,043	$326,082	$347,284